COLOMBO – August 31, 2026 – Asiri Hospital Holdings PLC, Sri Lanka’s largest and most advanced private healthcare provider, today announced its Annual Report for the financial year ended March 31, 2026, showcasing significant financial growth, strategic expansion, and an unwavering commitment to clinical excellence. The report, themed “NURTURING A LIFE WITHOUT LIMITS,” highlights the Group’s resilient performance amidst a gradually recovering economy and its proactive investments in advanced healthcare solutions.
Strong Financials Underpin Growth Trajectory
For the financial year 2025/26, Asiri Hospital Holdings PLC reported impressive financial results:
- Revenue: Grew to LKR 35,057 million, an increase from LKR 31,022 million in the previous year.
- Net Profit: Rose significantly to LKR 3,060 million, compared to LKR 1,826 million in FY 2024/25.
- Earnings Per Share (EPS): Improved to LKR 2.44, up from LKR 1.44, reflecting enhanced profitability.
- Total Assets: Increased to LKR 60,196 million, demonstrating continued investment in infrastructure.
- Shareholder’s Funds: Expanded to LKR 23,736 million, reflecting growing stakeholder value.
These figures underscore the Group’s capacity to generate sustainable value even in a dynamic economic landscape, reaffirming its strong financial position and operational efficiency.
Pioneering Innovation and Strategic Expansion
The Annual Report details several landmark achievements and strategic initiatives that advanced Asiri Health’s mission to deliver world-class healthcare:
- Sri Lanka’s First Robotic Surgery Programme: A defining achievement of the year, this initiative positions Asiri at the forefront of next-generation surgical care, offering greater precision, faster recovery, and improved patient outcomes.
- Asiri Liver Transplant Centre: The establishment of a dedicated unit has introduced liver transplantation as a new surgical service, supported by intensive monitoring and multidisciplinary management.
- Enhanced Specialised Care: Continued investments strengthened capabilities in tertiary and quaternary care across transplant medicine, advanced cardiovascular services, neurosciences, oncology, and diagnostic medicine.
- Regional Outreach: Asiri’s regional hospitals, including Kandy, Galle, and Matara, expanded their specialised care offerings. Notably, Asiri Hospital Matara commissioned the first Cardiac Catheterization Laboratory in the Matara District, significantly improving access to advanced cardiac diagnostics and interventional procedures in Southern Sri Lanka.
- Asiri Academy of Health Sciences: The Academy expanded its operational footprint, delivering world-class healthcare education and creating clear professional pathways, including a BSc (Hons) Nursing Top-Up Degree from London Metropolitan University.
Commitment to Quality, Governance, and Sustainability
Asiri Hospital Holdings PLC reiterated its dedication to maintaining the highest standards of quality and governance:
- Accreditations: All Group hospitals continue to meet global accreditation standards set by the Joint Commission International (JCI) and the Australian Council on Healthcare Standards International (ACHSI). Asiri Laboratories maintained ISO certification for diagnostic precision.
- Brand Recognition: Asiri Central Hospital was ranked No. 1 in LMD’s Most Loved Hospital Brands for 2025, with Asiri Surgical Hospital and Asiri Health also featuring in the Top 10, highlighting strong public trust.
- Corporate Governance: The Group proactively adopts robust governance policies and practices, ensuring accountability, independence, and effective risk management across all levels of the organisation, with climate-related and broader sustainability risks formally integrated into its risk management policy (SLFRS S1 and S2 disclosures).
Navigating Challenges and Future Outlook
Despite an improving macroeconomic environment, the Group faced challenges such as exchange rate volatility, elevated utility costs, and the devastation caused by Cyclone Ditwah in November 2025. The cyclone resulted in an estimated revenue loss of LKR 167.96 million and asset loss of LKR 13.01 million, which was assessed as a material impact under the Group’s climate risk assessment methodology. Nevertheless, Asiri Health delivered uninterrupted services and maintained its growth trajectory.
Looking ahead, Asiri plans further strategic investments, including the development of a purpose-built standalone oncology hospital, expected to be completed by Q2 2029. The Group is also strategically positioning itself to capture a greater share of the medical tourism market, particularly from Bangladesh, Maldives, and Seychelles, leveraging its internationally accredited hospitals and specialised clinical capabilities through a newly established International Patient Centre (IPC).
Asiri Hospital Holdings PLC remains committed to shaping the future of healthcare in Sri Lanka through innovation, compassion, and an unwavering pursuit of clinical excellence, fostering a healthier and more prosperous future for all stakeholders.
Source: Read original document
